|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
As Canada becomes the second country after Uruguay to allow recreational use of cannabis, advances in pot research could follow.
'There's so much momentum -- and Canada helps with that momentum,' one expert says.
These names should stoke up your portfolio.
On Wednesday, Canada becomes the first major economy to legalize the recreational use of cannabis.
These three topics will be top of mind on Tuesday.
Aurora Cannabis prepares for an NYSE listing, and the sad story of Sears.
While Tilt may be a little harder for some to wrap their heads around, it could pay off for cannabis investors.
The DEA will now classify certain drug products to containing cannabidiol as schedule V.
Marijuana has gone from an ancient medicinal herb to an edible gummy bear -- but how has the plant's tumultuous past impacted its future market?
We’re selling Aurora Cannabis to lock in profits after its unexpectedly strong run-up.
The only other option is 'to fearfully wait' for the legal-weed industry to expand.
The mechanism for rational price discovery, at least in Tilray, appears to be irrational at the moment.
Covered calls may be the best bet -- or wait for a dip.
The approval Tilray Inc. received to import a cannabis-based product for a clinical trial in the U.S. propels higher shares of marijuana-related companies, including two in our portfolio.
Expect more companies to join Coca-Cola, Molson Coors and Constellation Brands in checking out the market.
Aurora Cannabis denies reports it was in talks with a beverage company to produce cannabis-infused drinks.
Tilray jumps after it receives approval from the U.S. Drug Enforcement Administration to import pharmaceutical-grade medical cannabis for a clinical trial.
Last week we re-initiated a position in Aurora Cannabis, exited USA Technologies and added to our holdings in Del Frisco's Restaurant Group.
A tie-up between the two could mark the first major U.S. firm to establish a line of CBD drinks.
The latest reports about Coke looking into cannabis confirms a broader industry trend.
With legal-weed firm Tilray up nearly 500% in seven weeks, we want to own rival company Aurora Cannabis again.
There is no denying the obvious consumer demand. There is no denying legal trends.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.